Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage, AI-driven precision oncology company, today announced the launch of ZetaOmics, the computational-biology module of its multi-agentic AI ...
More than a decade after Alice Corp. v. CLS Bank Int’l, the two-step framework for patent eligibility under 35 U.S.C. § 101 remains as contentious ...
Some memories remain with us for years, shaping how we learn from experience and adapt to the world around us. Others ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results